Pneumococcal Vaccines Market Indsutry Growth, Outlook and Analysis By 2018–2026

Page 1

Pneumococcal Vaccines Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026

© Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Pneumococcal Vaccines Market – Overview Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine. Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than 2 years old, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. CDC recommends pneumococcal polysaccharide vaccine for all adults 65 years or older, people 2-64 years old with certain medical conditions, and adults 19-64 years old who smoke cigarettes. The global pneumococcal vaccines market size was valued at US$ 7,376.6 million in 2018 and is expected to witness a CAGR of 7.5% over the forecast period (2018 – 2026). High mortality due to pneumonia among the global population is expected to increase adoption of pneumococcal vaccines over the forecast period. For instance, according to the World Health Organization (WHO) November 2016, pneumonia accounted for 16% of all deaths of children under 5 years old in 2015, with 920,136 deaths globally.

© Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Pneumococcal Vaccines Market Taxonomy: By Vaccine Type: PCV10 PCV13 PPSV23 By Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Pharmacies Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2295 © Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Pneumococcal Vaccines Market: Key Players ●

Pfizer, Inc.

Merck & Co. Inc.

GlaxoSmithKline plc.

Various manufacturers are focused on new projects that target diseases with no existing vaccine for various age groups. For instance, in April 2018, Merck, which is also known as MSD outside of the U.S. and Canada, started two Phase 3 studies for PCV-15 (V114), an investigational polyvalent conjugate vaccine against pneumococcal disease. View this report @ https://www.coherentmarketinsights.com/market-insight/pneumococcal-vaccines-market-2295

© Coherent market Insights. All Rights Reserved


ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

Š Coherent market Insights. All Rights Reserved


ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL IMAGING

PHARMACEUTICAL

MEDICAL DEVICES

Chemicals & Materials

Bulk Chemicals

Advanced

Materials

Speciality and Fine Chemicals

Green Chemicals Food Ingredients

© Coherent market Insights. All Rights Reserved

Cosmetic Ingredients

Polymers & Resins


ABOUT COHERENT MARKET INSIGHTS KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+

Insights Published Per Year

150+

Consulting Projects Till Date

125+

Clients Worldwide Per Year

110+

COUNTRY ANALYSIS

CONSULT PROJECTS

SURVEY RESEARC H

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved


To know more about us, visit our website: www.coherentmarketinsights.com

THANK YOU

Š Coherent market Insights. All Rights Reserved

For sales queries or new topics emailus on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.